Patents by Inventor Vanessa Bres

Vanessa Bres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230227922
    Abstract: There is described herein a method for specifically detecting Babesia species nucleic acid in a sample, which in one aspect comprises: (1) contacting a sample, said sample suspected of containing Babesia species nucleic acid, with at least two oligomers for amplifying a target region of a Babesia species target nucleic acid, wherein the at least two amplification oligomers comprise: (a) a first amplification oligomer comprising a first target-hybridizing sequence (i) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:66 and comprises SEQ ID NO:56 or 57; or (ii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:96 and comprises SEQ ID NO:101; or (iii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:97 and comprises SEQ ID NO:101; (iv) comprises or consists of SEQ ID NO:8; (v) comprises or consists of SEQ ID NO:83 and (b) a second am
    Type: Application
    Filed: January 25, 2023
    Publication date: July 20, 2023
    Inventors: Vanessa BRES, Deanna SELF, Jeffrey M. LINNEN
  • Publication number: 20230220499
    Abstract: The medical field of COVID-19 diagnosis relates to methods for detecting SARS-CoV-2 nucleic acids in a sample as well as combinations of oligomers for determining the presence or absence of SARS-CoV-2 in a Sample.
    Type: Application
    Filed: May 7, 2021
    Publication date: July 13, 2023
    Inventors: Kui GAO, Anthony JAMES, Vanessa BRES
  • Patent number: 11667978
    Abstract: There is described herein a method for specifically detecting Babesia species nucleic acid in a sample, which in one aspect comprises: (1) contacting a sample, said sample suspected of containing Babesia species nucleic acid, with at least two oligomers for amplifying a target region of a Babesia species target nucleic acid, wherein the at least two amplification oligomers comprise: (a) a first amplification oligomer comprising a first target-hybridizing sequence (i) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:66 and comprises SEQ ID NO:56 or 57; or (ii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:96 and comprises SEQ ID NO:101; or (iii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:97 and comprises SEQ ID NO:101; (iv) comprises or consists of SEQ ID NO:8; (v) comprises or consists of SEQ ID NO:83 and (b) a second am
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: June 6, 2023
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Vanessa Bres, Deanna Self, Jeffrey M. Linnen
  • Publication number: 20220243285
    Abstract: Disclosed are nucleic acid oligomers, including amplification oligomers, detection probes, and capture probes, for detection of Plasmodium species nucleic acid in a sample.
    Type: Application
    Filed: December 20, 2019
    Publication date: August 4, 2022
    Inventors: Deanna Self, Jeffrey M. Linnen, Vanessa Bres
  • Publication number: 20210079485
    Abstract: There is described herein a method for specifically detecting Babesia species nucleic acid in a sample, which in one aspect comprises: (1) contacting a sample, said sample suspected of containing Babesia species nucleic acid, with at least two oligomers for amplifying a target region of a Babesia species target nucleic acid, wherein the at least two amplification oligomers comprise: (a) a first amplification oligomer comprising a first target-hybridizing sequence (i) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:66 and comprises SEQ ID NO:56 or 57; or (ii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:96 and comprises SEQ ID NO:101; or (iii) that is from about 15 to about 33 contiguous nucleotides in length, is contained in the sequence of SEQ ID NO:97 and comprises SEQ ID NO:101; (iv) comprises or consists of SEQ ID NO:8; (v) comprises or consists of SEQ ID NO:83 and (b) a second am
    Type: Application
    Filed: June 6, 2018
    Publication date: March 18, 2021
    Inventors: Vanessa Bres, Deanna Self, Jeffrey M. Linnen
  • Patent number: 8372819
    Abstract: Provided herein are methods and compositions for modulating apoptosis by targeting SKIP (Ski-interacting protein) activity. Methods of increasing DNA damage-induced cell death in cancer cells, and reducing DNA damage-induced cell death in normal cells are provided.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: February 12, 2013
    Assignee: Salk Institute for Biological Studies
    Inventors: Katherine Jones, Lirong Zhang, Vanessa Bres, Yupeng Chen
  • Publication number: 20110269819
    Abstract: Provided herein are methods and compositions for modulating apoptosis by targeting SKIP (Ski-interacting protein) activity. Methods of increasing DNA damage-induced cell death in cancer cells, and reducing DNA damage-induced cell death in normal cells are provided.
    Type: Application
    Filed: April 1, 2011
    Publication date: November 3, 2011
    Inventors: Katherine Jones, Lirong Zhang, Vanessa Bres, Yupeng Chen